Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Astec Lifesciences's Revenue for the
three
months ended in Mar. 2026 was ₹1,586 Mil. Astec Lifesciences's average Accounts Receivable for the
three
months ended in Mar. 2026 was ₹2,477 Mil.
Hence, Astec Lifesciences's Receivables Turnover for the
three
months ended in Mar. 2026 was 0.64.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Astec Lifesciences Receivables Turnover Related Terms
Astec Lifesciences Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Astec Lifesciences's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTEC vs CTVA, CF, MOS: Receivables Turnover Comparison
For the Agricultural Inputs subindustry, Astec Lifesciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences Receivables Turnover vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astec Lifesciences (NSE:ASTEC) has a Receivables Turnover of 0.64 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Astec Lifesciences and its competitors. According to the industry distribution chart, Astec Lifesciences ranks #212 out of 245 companies in the Agriculture industry, placing it in the top 86.5%.
Is Astec Lifesciences' Receivables Turnover too high?
Astec Lifesciences' current Receivables Turnover is 0.64. The Agriculture industry median Receivables Turnover is 5.43. Astec Lifesciences' value of 0.64 is 88.2% below this industry median. Based on the distribution chart, Astec Lifesciences ranks #212 out of 245 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Astec Lifesciences has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Receivables Turnover compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #212 out of 245 companies for Receivables Turnover. This places Astec Lifesciences in the lower half of its industry. The industry median Receivables Turnover is 5.43. Astec Lifesciences' value of 0.64 is 88.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for an Agriculture company?
The median Receivables Turnover among Agriculture companies is 5.43, based on 245 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astec Lifesciences's current Receivables Turnover of 0.64 is 88.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Astec Lifesciences and its competitors. For the Agriculture industry, the median Receivables Turnover is 5.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astec Lifesciences's current Receivables Turnover is 0.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹991.75, compared to a current price of ₹682.70 — trading 31.2% below its estimated fair value. The current Receivables Turnover is 0.64 and 88.2% below the Agriculture industry median of 5.43. Astec Lifesciences' overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Receivables Turnover is 0.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued.
The current stock price of ₹682.70 is trading 31.2% below its estimated GF Value™ of ₹991.75.
GuruFocus considers Astec Lifesciences to be Significantly Undervalued.
Key valuation signals for NSE:ASTEC:
Receivables Turnover: 0.64
GF Value™: ₹991.75 vs. price of ₹682.70 (31.2% below fair value)
Industry Position: 88.2% below the Agriculture median (#212 of 245)
No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
76GF Score
Get the complete analysis for NSE:ASTEC
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTEC has been successfully added to your 
